Navidea Biopharmaceuticals Inc. (NAVB) Dipped -5.26% or -0.02 To Price $0.27 On Tuesday


Navidea Biopharmaceuticals Inc. (NAVB) dipped -5.26% or -0.02 to $0.27. It is around 87282 shares traded, which is 24.62% compare to the average total volume 354489. The market cap of NAVB is $43.95 million. The year to date change is -26.74%. The 52 week price range is from $0.27 to $0.68. Price of NAVB have changed -1.86% during last week. It have changed -13.32% over last month, -21.25% over last 3 months, -34.03% over last 6 months and -42.54% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NAVB is 0.35. It is 29.63% above current price. The 200-day Moving Averages for NAVB is 0.40. It is 48.15% above current price. The 52-week High is 0.68. It is 151.85% from the current price. The 52-week Low is 0.27. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NAVB is 12.42 on 2018-04-13. Short % to float is 2.74%. There are some statistics of NAVB. It is has market cap $43.95 million. The share outstanding is 162.78 million. The average volume is 354489. The percent of top 15 Institution holding is 7.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NAVB is -264.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NAVB is 450.90%.


Tags:

Share this post